Page last updated: 2024-08-25

bexarotene and mdv 3100

bexarotene has been researched along with mdv 3100 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dar, JA; Eisermann, K; Feturi, FG; Johnston, PA; Kenefake, AN; Masoodi, KZ; Nelson, JB; Nguyen, M; O'Malley, K; Parrinello, E; Pascal, LE; Wang, Z; Wipf, P; Yang, Z1

Other Studies

1 other study(ies) available for bexarotene and mdv 3100

ArticleYear
Inhibition of Androgen Receptor Function and Level in Castration-Resistant Prostate Cancer Cells by 2-[(isoxazol-4-ylmethyl)thio]-1-(4-phenylpiperazin-1-yl)ethanone.
    Endocrinology, 2017, 10-01, Volume: 158, Issue:10

    Topics: Androgen Receptor Antagonists; Animals; Benzamides; Bexarotene; Binding Sites; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression; Humans; Isoxazoles; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Nitriles; Phenylthiohydantoin; Piperazines; Promoter Regions, Genetic; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Real-Time Polymerase Chain Reaction; Receptors, Androgen; Tetrahydronaphthalenes; Xenograft Model Antitumor Assays

2017